EMA qualification
PathAI’s AIM-MASH AI Assist Receives Historic FDA Qualification for MASH Clinical Trials
PathAI; AIM-MASH; AI Assist; FDA qualification; Drug Development Tool; biomarker qualification; MASH; MASLD; NASH; metabolic dysfunction-associated steatohepatitis; AI pathology; clinical trials; EMA qualification; liver biopsy; histology